Biotechnology News and Industry Updates
UK launches AI biosecurity lab with up to £300 million backing
The UK is establishing a dedicated AI Biosecurity Lab as part of a broader national initiative to strengthen resilience against biological threats. The organisation is backed by £100 million in ...
Windward Bio files for U.S. IPO as biotech listings regain momentum
Biotech companies are among the more active issuers in this fall's IPO market, despite rising bond yields and concerns about the AI trade weighing on broader risk appetite. Windward Bio joins that ...
Warhound launches with $200 million seed round to supply genetically screened military dogs
The U.S. military relies heavily on working dogs imported from Europe, where supply is tightening and washout rates remain high after years of training. Warhound is now emerging from stealth in ...
U.S. Treasury proposes outbound investment rules, drops Venezuela from restricted country list
Washington is advancing a broader national security framework for overseas capital flows as the U.S. Treasury opens a rulemaking process on investments in sensitive foreign sectors. The proposal ...
Moderna and Merck melanoma vaccine combo cuts recurrence or death risk in Phase 3 trial
Detailed Phase 3 results show the personalized mRNA cancer vaccine developed by Moderna and Merck improves outcomes for melanoma patients when used with Keytruda after surgery. The findings, based ...
Moderna shares slide after leaked cancer vaccine trial data
Moderna shares come under pressure after partial data on its closely watched cancer vaccine reaches the market before the full release. The later disclosure still appears to meet Wall Street ...
Warp Sciences launches drug development AI startup with $215 million funding
After leading OpenAI's AI-for-science efforts, Kevin Weil is launching a new company focused on accelerating a critical step in drug development with artificial intelligence. The startup, Warp ...
